{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:23:22Z","timestamp":1793226202285,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:00:00Z","timestamp":1494374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:00:00Z","timestamp":1494374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperactivated <jats:italic>Ras<\/jats:italic> regulates many oncogenic pathways in several malignant human cancers including glioblastoma and it is an attractive target for cancer therapies. <jats:italic>Ras<\/jats:italic> activation in cancer cells drives protein internalization via macropinocytosis as a key nutrient-gaining process. By utilizing this unique endocytosis pathway, here we create a biologically inspired nanostructure that can induce cancer cells to \u2018drink drugs\u2019 for targeting activating transcription factor-5 (ATF5), an overexpressed anti-apoptotic transcription factor in glioblastoma. Apolipoprotein E3-reconstituted high-density lipoprotein is used to encapsulate the siRNA-loaded calcium phosphate core and facilitate it to penetrate the blood\u2013brain barrier, thus targeting the glioblastoma cells in a macropinocytosis-dependent manner. The nanostructure carrying ATF5 siRNA exerts remarkable RNA-interfering efficiency, increases glioblastoma cell apoptosis and inhibits tumour cell growth both <jats:italic>in vitro<\/jats:italic> and in xenograft tumour models. This strategy of targeting the macropinocytosis caused by <jats:italic>Ras<\/jats:italic> activation provides a nanoparticle-based approach for precision therapy in glioblastoma and other <jats:italic>Ras<\/jats:italic>-activated cancers.<\/jats:p>","DOI":"10.1038\/ncomms15144","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T12:36:29Z","timestamp":1494419789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":182,"title":["Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Jia-Lin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Xiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Hua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ming","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Guo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Zhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,10]]},"reference":[{"key":"BFncomms15144_CR1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1158\/1078-0432.CCR-14-2662","volume":"21","author":"F McCormick","year":"2015","unstructured":"McCormick, F. KRas as a therapeutic target. Clin. Cancer Res. 21, 1797\u20131801 (2015).","journal-title":"Clin. Cancer Res."},{"key":"BFncomms15144_CR2","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1158\/1078-0432.CCR-14-2148","volume":"21","author":"K Marcus","year":"2015","unstructured":"Marcus, K. & Mattos, C. Direct attack on Ras: intramolecular communication and mutation-specific effects. Clin. Cancer Res. 21, 1810\u20131818 (2015).","journal-title":"Clin. Cancer Res."},{"key":"BFncomms15144_CR3","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/1078-0432.CCR-14-3214","volume":"21","author":"AD Cox","year":"2015","unstructured":"Cox, A. D., Der, C. J. & Philips, M. R. Targeting Ras membrane association: back to the future for anti-Ras drug discovery? Clin. Cancer Res. 21, 1819\u20131827 (2015).","journal-title":"Clin. Cancer Res."},{"key":"BFncomms15144_CR4","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nrd4281","volume":"13","author":"AA Samatar","year":"2014","unstructured":"Samatar, A. A. & Poulikakos, P. I. Targeting Ras-Erk signalling in cancer: promises and challenges. Nat. Rev. Drug Discov. 13, 928\u2013942 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFncomms15144_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nature01451","volume":"422","author":"SD Conner","year":"2003","unstructured":"Conner, S. D. & Schmid, S. L. Regulated portals of entry into the cell. Nature 422, 37\u201344 (2003).","journal-title":"Nature"},{"key":"BFncomms15144_CR6","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.1038\/srep10300","volume":"5","author":"I Nakase","year":"2015","unstructured":"Nakase, I., Kobayashi, N. B., Takatani-Nakase, T. & Yoshida, T. Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes. Sci. Rep. 5, 10300 (2015).","journal-title":"Sci. Rep."},{"key":"BFncomms15144_CR7","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","volume":"72","author":"IA Prior","year":"2012","unstructured":"Prior, I. A., Lewis, P. D. & Mattos, C. A comprehensive survey of Ras mutations in cancer. Cancer Res. 72, 2457\u20132467 (2012).","journal-title":"Cancer Res."},{"key":"BFncomms15144_CR8","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","volume":"21","author":"AC Kimmelman","year":"2015","unstructured":"Kimmelman, A. C. Metabolic dependencies in Ras-driven cancers. Clin. Cancer Res. 21, 1828\u20131834 (2015).","journal-title":"Clin. Cancer Res."},{"key":"BFncomms15144_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature12138","volume":"497","author":"C Commisso","year":"2013","unstructured":"Commisso, C. et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497, 633\u2013637 (2013).","journal-title":"Nature"},{"key":"BFncomms15144_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son, J. et al. Glutamine supports pancreatic cancer growth through a KRas-regulated metabolic pathway. Nature 496, 101\u2013105 (2013).","journal-title":"Nature"},{"key":"BFncomms15144_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1158\/1541-7786.MCR-07-2036","volume":"6","author":"JH Overmeyer","year":"2008","unstructured":"Overmeyer, J. H., Kaul, A., Johnson, E. E. & Maltese, W. A. Active Ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis. Mol. Cancer Res. 6, 965\u2013977 (2008).","journal-title":"Mol. Cancer Res."},{"key":"BFncomms15144_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.canlet.2014.06.008","volume":"351","author":"Y Qian","year":"2014","unstructured":"Qian, Y. et al. Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells. Cancer Lett. 351, 242\u2013251 (2014).","journal-title":"Cancer Lett."},{"key":"BFncomms15144_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2014.02.021","volume":"157","author":"SS Kitambi","year":"2014","unstructured":"Kitambi, S. S. et al. Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule. Cell 157, 313\u2013328 (2014).","journal-title":"Cell"},{"key":"BFncomms15144_CR14","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1097\/00006123-199912000-00034","volume":"45","author":"MM Feldkamp","year":"1999","unstructured":"Feldkamp, M. M., Lala, P., Lau, N., Roncari, L. & Guha, A. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery 45, 1442\u20131453 (1999).","journal-title":"Neurosurgery"},{"key":"BFncomms15144_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1017\/S0317167100034272","volume":"25","author":"A Guha","year":"1998","unstructured":"Guha, A. Ras activation in astrocytomas and neurofibromas. Can. J. Neurol. Sci. 25, 267\u2013281 (1998).","journal-title":"Can. J. Neurol. Sci."},{"key":"BFncomms15144_CR16","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/nn4058215","volume":"8","author":"QX Song","year":"2014","unstructured":"Song, Q. X. et al. Lipoprotein-based nanoparticles rescue the memory loss of mice with alzheimer\u2019s disease by accelerating the clearance of amyloid-beta. ACS Nano 8, 2345\u20132359 (2014).","journal-title":"ACS Nano"},{"key":"BFncomms15144_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak, R. G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98\u2013110 (2010).","journal-title":"Cancer Cell"},{"key":"BFncomms15144_CR18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.18632\/oncotarget.180","volume":"1","author":"Z Sheng","year":"2010","unstructured":"Sheng, Z., Evans, S. K. & Green, M. R. An activating transcription factor 5-mediated survival pathway as a target for cancer therapy? Oncotarget 1, 457\u2013460 (2010).","journal-title":"Oncotarget"},{"key":"BFncomms15144_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2011.10.020","volume":"158","author":"J Li","year":"2012","unstructured":"Li, J., Yang, Y. & Huang, L. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. J. Control Release 158, 108\u2013114 (2012).","journal-title":"J. Control Release"},{"key":"BFncomms15144_CR20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.172.3990.1339","volume":"172","author":"JM Cotmore","year":"1971","unstructured":"Cotmore, J. M., Nichols, G. J. & Wuthier, R. E. Phospholipid-calcium phosphate complex: enhanced calcium migration in the presence of phosphate. Science 172, 1339\u20131341 (1971).","journal-title":"Science"},{"key":"BFncomms15144_CR21","doi-asserted-by":"publisher","first-page":"7328","DOI":"10.1021\/bi036208p","volume":"43","author":"JE Croy","year":"2004","unstructured":"Croy, J. E., Brandon, T. & Komives, E. A. Two apolipoprotein E mimetic peptides, ApoE (130\u2013149) and ApoE(141\u2013155)2, bind to LRP1. Biochemistry 43, 7328\u20137335 (2004).","journal-title":"Biochemistry"},{"key":"BFncomms15144_CR22","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/prot.20080","volume":"55","author":"M Prevost","year":"2004","unstructured":"Prevost, M. & Raussens, V. Apolipoprotein E-low density lipoprotein receptor binding: study of protein\u2013protein interaction in rationally selected docked complexes. Proteins 55, 874\u2013884 (2004).","journal-title":"Proteins"},{"key":"BFncomms15144_CR23","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1074\/jbc.274.11.7011","volume":"274","author":"C Fillebeen","year":"1999","unstructured":"Fillebeen, C. et al. Receptor-mediated transcytosis of lactoferrin through the blood\u2013brain barrier. J. Biol. Chem. 274, 7011\u20137017 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFncomms15144_CR24","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/mt.2011.186","volume":"19","author":"H Kuwahara","year":"2011","unstructured":"Kuwahara, H. et al. Efficient in vivo delivery of siRNA into brain capillary endothelial cells along with endogenous lipoprotein. Mol. Ther. 19, 2213\u20132221 (2011).","journal-title":"Mol. Ther."},{"key":"BFncomms15144_CR25","doi-asserted-by":"publisher","first-page":"9171","DOI":"10.1016\/j.biomaterials.2013.08.039","volume":"34","author":"B Zhang","year":"2013","unstructured":"Zhang, B. et al. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Biomaterials 34, 9171\u20139182 (2013).","journal-title":"Biomaterials"},{"key":"BFncomms15144_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/smll.201001589","volume":"7","author":"M Yang","year":"2011","unstructured":"Yang, M. et al. Efficient cytosolic delivery of siRNA using HDL-mimicking nanoparticles. Small 7, 568\u2013573 (2011).","journal-title":"Small"},{"key":"BFncomms15144_CR27","first-page":"2300","volume":"60","author":"L Maletinska","year":"2000","unstructured":"Maletinska, L. et al. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res. 60, 2300\u20132303 (2000).","journal-title":"Cancer Res."},{"key":"BFncomms15144_CR28","first-page":"2799","volume":"57","author":"M Yamamoto","year":"1997","unstructured":"Yamamoto, M. et al. Increased expression of low density lipoprotein receptor-related protein\/alpha2-macroglobulin receptor in human malignant astrocytomas. Cancer Res. 57, 2799\u20132805 (1997).","journal-title":"Cancer Res."},{"key":"BFncomms15144_CR29","doi-asserted-by":"crossref","first-page":"29874","DOI":"10.1016\/S0021-9258(18)43962-2","volume":"269","author":"G Bu","year":"1994","unstructured":"Bu, G., Maksymovitch, E. A., Geuze, H. & Schwartz, A. L. Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells. J. Biol. Chem. 269, 29874\u201329882 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFncomms15144_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-59745-178-9_2","volume":"440","author":"AI Ivanov","year":"2008","unstructured":"Ivanov, A. I. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol. Biol. 440, 15\u201333 (2008).","journal-title":"Methods Mol. Biol."},{"key":"BFncomms15144_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0962-8924(00)89101-1","volume":"5","author":"JA Swanson","year":"1995","unstructured":"Swanson, J. A. & Watts, C. Macropinocytosis. Trends Cell Biol. 5, 424\u2013428 (1995).","journal-title":"Trends Cell Biol."},{"key":"BFncomms15144_CR32","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1016\/j.jprot.2012.06.038","volume":"75","author":"G Ikonomou","year":"2012","unstructured":"Ikonomou, G. et al. Interplay between oncogenic K-Ras and wild-type H-Ras in Caco-2 cell transformation. J. Proteomics 75, 5356\u20135369 (2012).","journal-title":"J. Proteomics"},{"key":"BFncomms15144_CR33","doi-asserted-by":"publisher","first-page":"e50701","DOI":"10.1371\/journal.pone.0050701","volume":"7","author":"YL Lin","year":"2012","unstructured":"Lin, Y. L. et al. KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells. PLoS ONE 7, e50701 (2012).","journal-title":"PLoS ONE"},{"key":"BFncomms15144_CR34","first-page":"3810","volume":"55","author":"K Aoki","year":"1995","unstructured":"Aoki, K., Yoshida, T., Sugimura, T. & Terada, M. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. Cancer Res. 55, 3810\u20133816 (1995).","journal-title":"Cancer Res."},{"key":"BFncomms15144_CR35","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/clinchem\/43.6.936","volume":"43","author":"E Lopez-Crapez","year":"1997","unstructured":"Lopez-Crapez, E., Chypre, C., Saavedra, J., Marchand, J. & Grenier, J. Rapid and large-scale method to detect K-ras gene mutations in tumor samples. Clin. Chem. 43, 936\u2013942 (1997).","journal-title":"Clin. Chem."},{"key":"BFncomms15144_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","volume":"9","author":"J Lee","year":"2006","unstructured":"Lee, J. et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391\u2013403 (2006).","journal-title":"Cancer Cell"},{"key":"BFncomms15144_CR37","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/sj.onc.1201455","volume":"15","author":"A Guha","year":"1997","unstructured":"Guha, A., Feldkamp, M. M., Lau, N., Boss, G. & Pawson, A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15, 2755\u20132765 (1997).","journal-title":"Oncogene"},{"key":"BFncomms15144_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/75596","volume":"25","author":"EC Holland","year":"2000","unstructured":"Holland, E. C. et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25, 55\u201357 (2000).","journal-title":"Nat. Genet."},{"key":"BFncomms15144_CR39","doi-asserted-by":"publisher","first-page":"8859","DOI":"10.1038\/ncomms9859","volume":"6","author":"S Bunda","year":"2015","unstructured":"Bunda, S. et al. Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis. Nat. Commun. 6, 8859 (2015).","journal-title":"Nat. Commun."},{"key":"BFncomms15144_CR40","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/neuonc\/nou096","volume":"16","author":"I Saga","year":"2014","unstructured":"Saga, I. et al. Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model. Neuro-Oncology 16, 1048\u20131056 (2014).","journal-title":"Neuro-Oncology"},{"key":"BFncomms15144_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0006-8993(99)01705-9","volume":"839","author":"JW Phillis","year":"1999","unstructured":"Phillis, J. W., Estevez, A. Y., Guyot, L. L. & O'Regan, M. H. 5-(N-Ethyl-N-isopropyl)-amiloride, an Na(+)\u2013H(+) exchange inhibitor, protects gerbil hippocampal neurons from ischemic injury. Brain Res. 839, 199\u2013202 (1999).","journal-title":"Brain Res."},{"key":"BFncomms15144_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrd2742","volume":"8","author":"KA Whitehead","year":"2009","unstructured":"Whitehead, K. A., Langer, R. & Anderson, D. G. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129\u2013138 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFncomms15144_CR43","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/ijc.22469","volume":"120","author":"SE Monaco","year":"2007","unstructured":"Monaco, S. E., Angelastro, J. M., Szabolcs, M. & Greene, L. A. The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines. Int. J. Cancer 120, 1883\u20131890 (2007).","journal-title":"Int. J. Cancer"},{"key":"BFncomms15144_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1471-4159.2008.05749.x","volume":"108","author":"LA Greene","year":"2009","unstructured":"Greene, L. A., Lee, H. Y. & Angelastro, J. M. The transcription factor ATF5: role in neurodevelopment and neural tumors. J. Neurochem. 108, 11\u201322 (2009).","journal-title":"J. Neurochem."},{"key":"BFncomms15144_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495\u2013516 (2007).","journal-title":"Toxicol. Pathol."},{"key":"BFncomms15144_CR46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/neu.2000.17.283","volume":"17","author":"BR Pike","year":"2000","unstructured":"Pike, B. R. et al. Stretch injury causes calpain and caspase-3 activation and necrotic and apoptotic cell death in septo-hippocampal cell cultures. J. Neurotrauma 17, 283\u2013298 (2000).","journal-title":"J. Neurotrauma"},{"key":"BFncomms15144_CR47","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/cr.2013.79","volume":"23","author":"FJ Zwartkruis","year":"2013","unstructured":"Zwartkruis, F. J. & Burgering, B. M. Ras and macropinocytosis: trick and treat. Cell Res. 23, 982\u2013983 (2013).","journal-title":"Cell Res."},{"key":"BFncomms15144_CR48","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1074\/jbc.M503202200","volume":"281","author":"IA Khalil","year":"2006","unstructured":"Khalil, I. A., Kogure, K., Futaki, S. & Harashima, H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem. 281, 3544\u20133551 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFncomms15144_CR49","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nm996","volume":"10","author":"JS Wadia","year":"2004","unstructured":"Wadia, J. S., Stan, R. V. & Dowdy, S. F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310\u2013315 (2004).","journal-title":"Nat. Med."},{"key":"BFncomms15144_CR50","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1021\/mp100366h","volume":"8","author":"XX Zhang","year":"2011","unstructured":"Zhang, X. X., Allen, P. G. & Grinstaff, M. Macropinocytosis is the major pathway responsible for DNA transfection in CHO cells by a charge-reversal amphiphile. Mol. Pharm. 8, 758\u2013766 (2011).","journal-title":"Mol. Pharm."},{"key":"BFncomms15144_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jconrel.2015.12.013","volume":"240","author":"F Zhang","year":"2015","unstructured":"Zhang, F., Lin, Y. A., Kannan, S. & Kannan, R. M. Targeting specific cells in the brain with nanomedicines for CNS therapies. J. Control Release 240, 212\u2013226 (2015).","journal-title":"J. Control Release"},{"key":"BFncomms15144_CR52","doi-asserted-by":"publisher","first-page":"17757","DOI":"10.1073\/pnas.0508677102","volume":"102","author":"G Zheng","year":"2005","unstructured":"Zheng, G., Chen, J., Li, H. & Glickson, J. D. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc. Natl Acad. Sci. USA 102, 17757\u201317762 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms15144_CR53","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/10611860290031877","volume":"10","author":"J Kreuter","year":"2002","unstructured":"Kreuter, J. et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood\u2013brain barrier. J. Drug Target 10, 317\u2013325 (2002).","journal-title":"J. Drug Target"},{"key":"BFncomms15144_CR54","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.1222742110","volume":"110","author":"D Wang","year":"2013","unstructured":"Wang, D. et al. Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood\u2013brain barrier. Proc. Natl Acad. Sci. USA 110, 2999\u20133004 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms15144_CR55","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1038\/ncomms5277","volume":"5","author":"KA Whitehead","year":"2014","unstructured":"Whitehead, K. A. et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun. 5, 4277 (2014).","journal-title":"Nat. Commun."},{"key":"BFncomms15144_CR56","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1038\/ncomms6565","volume":"5","author":"AT Press","year":"2014","unstructured":"Press, A. T. et al. Cell type-specific delivery of short interfering RNAs by dye-functionalised theranostic nanoparticles. Nat. Commun. 5, 5565 (2014).","journal-title":"Nat. Commun."},{"key":"BFncomms15144_CR57","doi-asserted-by":"publisher","first-page":"7930","DOI":"10.1038\/ncomms8930","volume":"6","author":"M Jang","year":"2015","unstructured":"Jang, M., Kim, J. H., Nam, H. Y., Kwon, I. C. & Ahn, H. J. Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription. Nat. Commun. 6, 7930 (2015).","journal-title":"Nat. Commun."},{"key":"BFncomms15144_CR58","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1021\/acsnano.5b03124","volume":"9","author":"M Huang","year":"2015","unstructured":"Huang, M. et al. GM1-modified lipoprotein-like nanoparticle: multifunctional nanoplatform for the combination therapy of Alzheimer's disease. ACS Nano 9, 10801\u201310816 (2015).","journal-title":"ACS Nano"},{"key":"BFncomms15144_CR59","doi-asserted-by":"publisher","first-page":"8002","DOI":"10.1016\/j.biomaterials.2014.05.081","volume":"35","author":"L Liu","year":"2014","unstructured":"Liu, L. et al. Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions. Biomaterials 35, 8002\u20138014 (2014).","journal-title":"Biomaterials"},{"key":"BFncomms15144_CR60","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1096\/fj.09-139865","volume":"24","author":"W Chen","year":"2010","unstructured":"Chen, W. et al. RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB J. 24, 1689\u20131699 (2010).","journal-title":"FASEB J."},{"key":"BFncomms15144_CR61","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1021\/nn506248s","volume":"9","author":"ZR Cohen","year":"2015","unstructured":"Cohen, Z. R. et al. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles. ACS Nano 9, 1581\u20131591 (2015).","journal-title":"ACS Nano"},{"key":"BFncomms15144_CR62","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3109\/1061186X.2015.1025077","volume":"23","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles. J. Drug Target 23, 832\u2013846 (2015).","journal-title":"J. Drug Target"},{"key":"BFncomms15144_CR63","first-page":"924","volume":"7","author":"Y Liu","year":"2012","unstructured":"Liu, Y., Miao, C., Wang, Z., He, X. & Shen, W. Survivin small interfering RNA suppresses glioblastoma growth by inducing cellular apoptosis. Neural Regen. Res. 7, 924\u2013931 (2012).","journal-title":"Neural Regen. Res."},{"key":"BFncomms15144_CR64","doi-asserted-by":"publisher","first-page":"152r","DOI":"10.1126\/scitranslmed.3006839","volume":"5","author":"SA Jensen","year":"2013","unstructured":"Jensen, S. A. et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci. Transl. Med. 5, 152r\u2013209r (2013).","journal-title":"Sci. Transl. Med."},{"key":"BFncomms15144_CR65","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/glia.10274","volume":"44","author":"J Saura","year":"2003","unstructured":"Saura, J., Tusell, J. M. & Serratosa, J. High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183\u2013189 (2003).","journal-title":"Glia"},{"key":"BFncomms15144_CR66","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"BFncomms15144_CR67","first-page":"e51088","volume":"83","author":"LA Hasselbach","year":"2014","unstructured":"Hasselbach, L. A. et al. Optimization of high grade glioma cell culture from surgical specimens for use in clinically relevant animal models and 3D immunochemistry. J. Vis. Exp. 83, e51088 (2014).","journal-title":"J. Vis. Exp."},{"key":"BFncomms15144_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0378-4347(96)00158-2","volume":"685","author":"C Lee","year":"1996","unstructured":"Lee, C. & Tannock, I. Pharmacokinetic studies of amiloride and its analogs using reversed-phase high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 685, 151\u2013157 (1996).","journal-title":"J. Chromatogr. B Biomed. Appl."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms15144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms15144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncomms15144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms15144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:01:29Z","timestamp":1671757289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms15144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,10]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,8,8]]}},"alternative-id":["BFncomms15144"],"URL":"https:\/\/doi.org\/10.1038\/ncomms15144","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,10]]},"assertion":[{"value":"27 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15144"}}